Targeting BACH1/PSPH axis suppresses bladder cancer progression and gemcitabine resistance by downregulating S100A2 expression
- 18 July 2025
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 241, 117182
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- KLF4 suppresses anticancer effects of brusatol via transcriptional upregulating NCK2 expression in melanomaBiochemical Pharmacology, 2024
- HOXB9 a miR-122–5p regulated gene, suppressed the anticancer effects of brusatol by upregulating SCD1 expression in melanomaBiomedicine & Pharmacotherapy, 2023
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 UpdateEuropean Urology, 2023
- ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restrictionCell Reports, 2021
- Bladder CancerJAMA, 2020
- BACH1 Stabilization by Antioxidants Stimulates Lung Cancer MetastasisCell, 2019
- Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1Cell, 2019
- Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancerBiochemical and Biophysical Research Communications, 2016
- Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesisBreast Cancer Research and Treatment, 2010
- Expression of -3-Phosphoserine Phosphatase Is Regulated by Reconstituted Basement MembraneBiochemical and Biophysical Research Communications, 2001